Product NDC: | 0002-7640 |
Proprietary Name: | Alimta |
Non Proprietary Name: | Pemetrexed disodium |
Active Ingredient(s): | 100 mg/4mL & nbsp; Pemetrexed disodium |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0002-7640 |
Labeler Name: | Eli Lilly and Company |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA021462 |
Marketing Category: | NDA |
Start Marketing Date: | 20080115 |
Package NDC: | 0002-7640-01 |
Package Description: | 1 VIAL in 1 CARTON (0002-7640-01) > 4 mL in 1 VIAL |
NDC Code | 0002-7640-01 |
Proprietary Name | Alimta |
Package Description | 1 VIAL in 1 CARTON (0002-7640-01) > 4 mL in 1 VIAL |
Product NDC | 0002-7640 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Pemetrexed disodium |
Dosage Form Name | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 20080115 |
Marketing Category Name | NDA |
Labeler Name | Eli Lilly and Company |
Substance Name | PEMETREXED DISODIUM |
Strength Number | 100 |
Strength Unit | mg/4mL |
Pharmaceutical Classes | Folate Analog Metabolic Inhibitor [EPC],Folic Acid Metabolism Inhibitors [MoA] |